• Corpus ID: 7986749

Female pattern hair loss may be triggered by low oestrogen to androgen ratio.

@article{RiedelBaima2008FemalePH,
  title={Female pattern hair loss may be triggered by low oestrogen to androgen ratio.},
  author={Bozena Riedel-Baima and Alexander Riedel},
  journal={Endocrine regulations},
  year={2008},
  volume={42 1},
  pages={
          13-6
        }
}
OBJECTIVE In both sexes the androgenetic alopecia is known to be mediated by the conversion of circulating androgens into dihydrotestosterone within the hair follicle. [...] Key MethodMETHODS We studied 20 premenopausal women with female pattern hair loss and 9 healthy women for serum levels of LH, FSH, estradiol, free and total testosterone, sex hormone binding globulin (SHBG) and dehydroepiandrosterone sulfate (DHEAS) on the first day of their menstrual cycle. Expand
Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
TLDR
Dihydrotestosterone is the most influential androgen and seems to play a very important role in the pathogenesis of androgenetic alopecia.
Trace elements content and hormonal profiles in women with androgenetic alopecia.
  • M. Skalnaya, V. P. Tkachev
  • Chemistry, Medicine
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements
  • 2011
TLDR
A routine treatment course of AGA patients, including topical inhibitor of 5-alpha-reductase and minoxidil, had no effect on the Cu hair content in occipital and frontal areas but there were positive changes in the morphological structure and other trace element contents.
Genetics and other factors in the aetiology of female pattern hair loss
TLDR
Hypotheses about possible pathomechanisms of FPHL as well as the results of the genetic studies performed to date suggest that the aetiology differs substantially from that of M‐AGA.
Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride.
TLDR
Finasteride is an efficient 5alpha-reductase inhibitor even at low doses of 1 mg/day, and in men treated with this dose for 12 months, there are mild differences in metabolic profile with slight amelioration of glucose metabolism regulation.
Female Pattern Hair Loss
TLDR
This review addresses the clinical presentation of female pattern hair loss, its differential diagnosis and treatment modalities, and describes off-label alternative modalities of treatment including 5-alfa reductase inhibitors, antiandrogens, estrogens, prostaglandin analogs, lasers, light treatments and hair transplantation.
Vitamin D Receptor Gene Polymorphisms Taq-1 and Cdx-1 in Female Pattern Hair Loss
TLDR
Taq-1 and Cdx-1 can be considered as risk factors for FPHL and may play role in disease persistence rather than disease initiation, suggesting failure of new anagen growth and decreased proliferation of hair follicle stem cells.
Alterations in Pattern Baldness According to Sex: Hair Metabolomics Approach
TLDR
The metabolic pathway in pattern baldness patients using hair samples was able to be confirmed for the first time, improving understanding of pattern balding and highlighting the need to link patterns of baldness and sex-related differences.
Vertex Accentuation in Female Pattern Hair Loss in Asians
Background: The most common cause of hair loss seen in women is female pattern hair loss (FPHL), also known as female androgenetic alopecia. It affects the central part of the scalp but spares the
Vertex Accentuation in Female Pattern Hair Loss
Background: The most common cause of hair loss seen in women is female pattern hair loss (FPHL), also known as female androgenetic alopecia. It affects the central part of the scalp, but spares the
Investigation of four novel male androgenetic alopecia susceptibility loci: no association with female pattern hair loss
TLDR
The results of this study provide no support for the hypothesis that the novel AGA loci influence susceptibility to FPHL.
...
1
2
3
4
...

References

SHOWING 1-10 OF 11 REFERENCES
Hormone studies in females with androgenic hairloss.
TLDR
Significantly elevated TSH levels prior to and after TRH stimulation in the hairloss group indicate that hypothyroidism may be an important hormonal disturbance in androgenic hairlOSS.
Androgenetic alopecia in women.
  • V. Price
  • Biology, Medicine
    The journal of investigative dermatology. Symposium proceedings
  • 2003
TLDR
The diagnosis of androgenetic alopecia in women is supported by early age of onset, the pattern of increased thinning over the frontal/parietal scalp with greater density over the occipital scalp, retention of the frontal hairline, and the presence of miniaturized hairs.
17α‐estradiol induces aromatase activity in intact human anagen hair follicles ex vivo
TLDR
Ex vivo experiments suggest that under the influence of 17α‐estradiol an increased conversion of testosterone to 17β‐mostradiol and androstendione to estrone takes place, which might explain the beneficial effects of estrogen treatment of AGA.
Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia.
TLDR
Findings revealed that both women and men have higher levels of receptors and 5alpha-reductase type I and II in frontal hair follices than in occipital follicles, whereasHigher levels of aromatase were found in their occipITAL follicles.
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
TLDR
In postmenopausal women with AGA, finasteride 1 mg/day taken for 12 months did not not increase hair growth or slow the progression of hair thinning.
Diffuse female hair loss: are androgens necessary?
TLDR
The case of a young woman with hypopituitarism who presented with the clinical and histological features of female androgenetic alopecia in the absence of detectable levels of circulating androgens or other signs of postpubertal androgenization is reported, showing that this pattern of hair loss is not necessarily androgen dependent.
Androgenetic alopecia in children: report of 20 cases
TLDR
A common feature observed in the series of prepubertal children with AGA was a strong genetic predisposition to the disease, and endocrine evaluation and a strict follow-up are strongly recommended.
[Assessment of efficacy of Diane-35 in androgenetic feminine alopecia].
TLDR
The study showed that Diane-35 used for 6-9 months decreases clearly the loss of hair, hair thinning and seborrhoea.
Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex
  • E. Ludwig
  • Biology, Medicine
    The British journal of dermatology
  • 1977
TLDR
A classification of the stages of the common form (female type) of androgenetic alopecia in women is presented and the exceptionally observed male type of androgyny can be classified according to Hamilton or to the modification of this classification proposed by Ebling & Rook.
Treatment of female pattern hair loss with oral antiandrogens
TLDR
It is shown that female pattern hair loss (FPHL) is either due to androgens or responsive to oral antiandrogen therapy, and this work has potential to help clarify the role of androgens and their role in hair loss.
...
1
2
...